Evidence map›Paper›PMID 41419816›Full record

ArticleBMC cancer2025

Addressing survivorship care gaps through digital innovation: opportunities, challenges, and ethical considerations in the e-QuoL project.

Charlotte Demoor-Goldschmidt, Gisela Michel, Jelena Roganovic, Isabelle Thierry-Chef, Päivi M Lähteenmäki, Monica Muraca, Zsuzsanna Jakab, Lola Chevenez, Emma J Potter, Miklós Garami and 3 more

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Charlotte Demoor-Goldschmidt *Pediatric Oncology-Hematology-Immunology Department, University Hospital of Angers, Angers, France. charlotte.demoorgoldschmidt@chu-angers.fr.
Gisela Michel *Faculty of Health Sciences and Medicine, University of Lucerne, Alpenquai 4, Lucerne, 6005, Switzerland.
Jelena RoganovicDepartment of Hematology and Oncology, Children's Hospital Zagreb, Zagreb, Croatia.
Isabelle Thierry-ChefBarcelona Institute of Global Health (ISGlobal), Doctor Aiguader, 88, Barcelona, 08003, Spain.
Päivi M LähteenmäkiDepartment of Pediatric and Adolescent Medicine, Turku University Hospital, and Turku University, Turku, Finland.
Monica MuracaDivision of Pediatric Hematology and Oncology, IRCCS Istituto Giannina Gasli, DOPO Clinic, ni, Genoa, Italy.
Zsuzsanna JakabNational Childhood Oncologic Registry, Hungarian Pediatric Oncology Network, Budapest, Hungary.
Lola ChevenezResilience, Paris, France.
Emma J PotterThe Royal Marsden Hospital, London, UK.
Miklós GaramiPediatric Center, Semmelweis University, Budapest, Hungary.
Kristen E T ThorntonDepartment of Behavioural Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
Hanne C LieDepartment of Behavioural Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
e-QuoL consortium

Funding

Horizon Europe 101136549United Kingdom Research and Innovation 10098114
6 · The paper itself

Abstract

backgroundChildhood, adolescent, and young adult cancers (CAYAC) present unique challenges in oncology. Advances in treatment Have led to an 80% 5-year survival rate; however, CAYAC survivors (CAYACS) remain at high risk of long-term medical and psychosocial complications, significantly impacting their quality of life. Short and long-term follow-up care is recommended, but is often fragmented, with considerable disparities in availability and accessibility across Europe. Many existing digital tools primarily address medical needs, leaving psychosocial challenges unaddressed. The e-QuoL project aims to bridge these gaps by leveraging existing digital health solutions to provide equitable, person-centered survivorship care.

methodsThe e-QuoL project employs a participatory approach involving survivors, families, healthcare professionals (HCP), and researchers. Using the FormIT methodology, the project follows three phases: Explore, Create, and Evaluate. The Explore phase includes a large-scale cross-sectional survey across 15 European countries to assess the unmet needs of CAYACS and their families. The Create phase involves co-creation workshops to develop and refine digital tools, including MyCaree-QuoL tool, which will supplement survivorship care passports, to provide personalized medical and psychosocial support. The Evaluate phase comprises usability testing and clinical studies in at least seven European countries to assess effectiveness, scalability, and real-world applicability. DISCUSSION: The e-QuoL project builds on existing digital health innovations while adapting them to diverse European healthcare systems. By developing MyCaree-QuoL, the project fosters a decentralized, person-centered model of survivorship care to promote equal access to quality survivorship support for CAYACS and HCPs. Ethical considerations, including data privacy, patient consent, and equitable access, are central to the project, with dedicated Ethics and Social Challenge Groups guiding implementation. Digital disparities remain a challenge, particularly for survivors from lower socio-economic backgrounds or remote areas. To mitigate this, e-QuoL will work with healthcare professionals to offer additional in-person support to complement digital interventions. The project aligns with Europe’s Beating Cancer Plan, aiming to improve quality of life and reduce disparities in care. By fostering collaboration among 30 partners across 15 countries and hosting resources on the PanCare website, e-QuoL seeks to ensure long-term impact, contributing to the goal of high-quality, equitable survivorship care across Europe.

Indexed as

Cancer SurvivorsNeoplasmsSurvivorshipAdolescentChildCross-Sectional StudiesDigital HealthEuropeFemaleHumansQuality of LifeYoung AdultAdolescent and young adult cancerChildhoodFollow-upLate effectsNeedsPsychosocialSupport

Identifiers

PMID41419816
PMCPMC12717762

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.